Background Primary prevention implantable cardioverter‐defibrillators (ICDs) reduce
mortality in selected patients with left ventricular systolic dysfunction by delivering therapies …

Background—Implantable cardioverter-defibrillators (ICDs) are increasingly used for primary
prevention after randomized, controlled trials demonstrating that they reduce the risk of …

Background—Although implantable cardioverter-defibrillators (ICDs) reduce mortality in
primary prevention patients with left ventricular systolic dysfunction, recent studies have …

Background—Although the use of implantable cardioverter-defibrillators (ICDs) for the
primary prevention of sudden cardiac death varies by sex, race, and hospital, geographic …

(ICDs) play a crucial role in the treatment of patients at heightened risk of sudden cardiac
death (SCD) caused by ventricular arrhythmias. The use of ICDs for primary prevention is …

Background Implantable cardioverter-defibrillators (ICDs) have been shown in primary
prevention efficacy trials to reduce mortality in patients with ischemic heart disease and left …

BACKGROUND: Clinical guidelines recommend implantable cardioverter-defibrillators
(ICDs) for selected patients with chronic left ventricular dysfunction (LVD) to improve …

Background—Contemporary patterns of use and outcomes of implantable cardioverter-
defibrillators (ICDs) in community practice settings are not well characterized. We assessed …

Background: Implantable cardioverter-defibrillators (ICDs) have a role in preventing cardiac
arrest in patients at risk for life-threatening ventricular arrhythmias. Purpose: To compare …

Background Although there is clear evidence to demonstrate that primary prevention
implantable defibrillators (ICDs) reduce mortality in high‐risk patients, ICDs are …